These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11526978)

  • 21. Anxiolytic-like effects of 7-nitroindazole in the rat plus-maze test.
    Yildiz F; Ulak G; Erden BF; Gacar N
    Pharmacol Biochem Behav; 2000 Feb; 65(2):199-202. PubMed ID: 10672969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benzodiazepine receptor function in the chick social separation-stress procedure.
    Watson GS; Roach JT; Sufka KJ
    Exp Clin Psychopharmacol; 1999 May; 7(2):83-9. PubMed ID: 10340149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of an anxiety-related phenotype in galanin overexpressing transgenic mice.
    Holmes A; Yang RJ; Crawley JN
    J Mol Neurosci; 2002; 18(1-2):151-65. PubMed ID: 11931346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Further evidence for differences between non-selective and BZ-1 (omega 1) selective, benzodiazepine receptor ligands in murine models of "state" and "trait" anxiety.
    Griebel G; Sanger DJ; Perrault G
    Neuropharmacology; 1996; 35(8):1081-91. PubMed ID: 9121611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of inbred mouse sensitivity to nitrous oxide antinociception with brain nitric oxide synthase activity following exposure to nitrous oxide.
    Henry ED; Ohgami Y; Li S; Chung E; Quock RM
    Pharmacol Biochem Behav; 2005 Aug; 81(4):764-8. PubMed ID: 15993935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing anxiety in C57BL/6J mice: a pharmacological characterization of the open-field and light/dark tests.
    Heredia L; Torrente M; Colomina MT; Domingo JL
    J Pharmacol Toxicol Methods; 2014; 69(2):108-14. PubMed ID: 24374104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of nitric oxide in benzodiazepines-induced antinociception in mice.
    Talarek S; Fidecka S
    Pol J Pharmacol; 2002; 54(1):27-34. PubMed ID: 12020041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sodium valproate decreases exploratory behaviour in mice: development of tolerance and cross-tolerance with chlordiazepoxide.
    File SE; Aranko K
    Eur J Pharmacol; 1988 Jul; 151(2):293-9. PubMed ID: 2844555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flavan-3-ol derivatives are positive modulators of GABA(A) receptors with higher efficacy for the alpha(2) subtype and anxiolytic action in mice.
    Fernandez SP; Mewett KN; Hanrahan JR; Chebib M; Johnston GA
    Neuropharmacology; 2008 Oct; 55(5):900-7. PubMed ID: 18657554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Putative anxiety-linked effects of the nitric oxide synthase inhibitor L-NAME in three murine exploratory behavior models.
    Czech DA; Jacobson EB; LeSueur-Reed KT; Kazel MR
    Pharmacol Biochem Behav; 2003 Jul; 75(4):741-8. PubMed ID: 12957214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered response to benzodiazepine anxiolytics in mice lacking GABA B(1) receptors.
    Mombereau C; Kaupmann K; van der Putten H; Cryan JF
    Eur J Pharmacol; 2004 Aug; 497(1):119-20. PubMed ID: 15321743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological modulation of stress-induced behavioral changes in the light/dark exploration test in male C57BL/6J mice.
    Ihne JL; Fitzgerald PJ; Hefner KR; Holmes A
    Neuropharmacology; 2012 Jan; 62(1):464-73. PubMed ID: 21906605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrinsic actions of benzodiazepine antagonists.
    File SE; Lister RG; Nutt DJ
    Neurosci Lett; 1982 Oct; 32(2):165-8. PubMed ID: 6292797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relations between open-field, elevated plus-maze, and emergence tests in C57BL/6J and BALB/c mice injected with GABA- and 5HT-anxiolytic agents.
    Lalonde R; Strazielle C
    Fundam Clin Pharmacol; 2010 Jun; 24(3):365-76. PubMed ID: 19735300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of ventral hippocampal nitric oxide/cGMP pathway in anxiety-related behaviors in rats submitted to the elevated T-maze.
    Calixto AV; Duarte FS; Duzzioni M; Nascimento Häckl LP; Faria MS; De Lima TC
    Behav Brain Res; 2010 Feb; 207(1):112-7. PubMed ID: 19800925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strain- and model-dependent effects of chlordiazepoxide, L-838,417 and zolpidem on anxiety-like behaviours in laboratory mice.
    Mathiasen LS; Mirza NR; Rodgers RJ
    Pharmacol Biochem Behav; 2008 Jul; 90(1):19-36. PubMed ID: 18321566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mouse light/dark box test.
    Bourin M; Hascoët M
    Eur J Pharmacol; 2003 Feb; 463(1-3):55-65. PubMed ID: 12600702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of chlordiazepoxide on the habituation of exploration: interactions with the benzodiazepine antagonist RO 15-1788.
    Lister RG; File SE
    Pharmacol Biochem Behav; 1987 Mar; 26(3):631-4. PubMed ID: 3033705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possible involvement of nitric oxide in chlordiazepoxide-induced anxiolysis in mice.
    Quock RM; Nguyen E
    Life Sci; 1992; 51(25):PL255-60. PubMed ID: 1280754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice.
    Takeda H; Tsuji M; Matsumiya T
    Eur J Pharmacol; 1998 May; 350(1):21-9. PubMed ID: 9683010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.